Tradestie Institutional Equity Comparison Engine

CAMP vs SGMT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SGMT Overall Edge

SGMT Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sagimet Biosciences Inc. Series A Common Stock (SGMT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CAMP trades at N/M Forward P/E with -991.8% operating margin (+138.9% YoY revenue) versus SGMT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SGMT sits in BREAKOUT (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CAMP N/M vs SGMT N/M Fwd P/E
Growth & Margin Winner SGMT
Op Margin -991.8% vs 0.0% ยท YoY +138.9% vs +0.0%
Momentum & Technical Winner SGMT
1Y -3.7% vs +25.6% ยท 52W Pos 22% vs 75%
Options & Structure Winner SGMT
UNCLASSIFIED (N/A IV) vs BREAKOUT (5th %ile IV)
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$3.95
+2.33% 1D
Market Cap $238.5M
1M Return +25.8%
1Y Return -3.66%
Forward P/E N/M
Unified AI Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0
SGMT NASDAQ
Sagimet Biosciences Inc. Series A Common Stock
Pharmaceutical Preparations
$9.73
-3.95% 1D
Market Cap $735.2M
1M Return +9.82%
1Y Return +25.55%
Forward P/E N/M
Unified AI Score
52.6 / 100 HOLD
Tech 36.0 Fund 54.0 Flow 69.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CAMP -3.66% SGMT +25.55% Spread: +29.21 pp (SGMT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CAMP Revenue SGMT Revenue CAMP Op. Margin SGMT Op. Margin Margin Edge
FY2023 $0M $0M -14822.6% -1537.0% SGMT
FY2024 $0M N/A -8142.3% N/A CAMP
FY2025 $0M N/A -1502.4% N/A CAMP

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CAMP (1) vs SGMT (6)
Institutional Metric CAMP SGMT Criterion Row Winner
Market Capitalization Scale $238.5M $735.2M Larger Scale SGMT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +138.9% +0.0% Higher Growth CAMP
Operating Margin (TTM) Profitability -991.8% 0.0% Higher Margin SGMT
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -146.1% -29.5% Higher ROE SGMT
52-Week Range Position Momentum 22% ($3โ€“$8) 75% ($4โ€“$11) Stronger Trend SGMT
Beta / 30D Volatility Risk Regime 1.34ฮฒ ยท 94% Vol 2.06ฮฒ ยท 83% Vol Lower Realized Risk SGMT
Unified Institutional Score Composite Signal 43.9 / 100 (HOLD) 52.6 / 100 (HOLD) Higher Composite SGMT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CAMP vs SGMT Buy Guide
CAMP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CAMP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SGMT BREAKOUT
141d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SGMT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CAMP nor SGMT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.